All filters
Slidesets
The population effect of HIV exposure in HIV-uninfected children on infant mortality in Botswana and South Africa- Dr. Amy Slogrove
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Developmental outcomes of breastfed, HIV-exposed uninfected and breastfed, HIV-unexposed children in the context of universal maternal antiretroviral therapy: a prospective cohort-Dr. Stanzi Le Roux
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
HIV -Affected but Not Infected – The Dilemma of HIV-Exposed but Uninfected Infants- Kathleen Powis, MD, MPH, MBA
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
The Second Generation: Pregnancy in Perinatal HIV Infected Women- Jennifer Jao, MD, MPH
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Inequality in mortality and access to antiretroviral therapy in adolescents living with perinatally-acquired HIV in sub-Saharan Africa: a Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration-Dr. Marcel Yotebieng
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Attrition and treatment outcomes among perinatally and behaviourally HIV-infected adolescents and youths in Thai National AIDS program- Dr. Sirinya Teeraananchai
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Experiences of transition to adult care and readiness to self-manage care in young people with perinatal HIV in England- Dr. Ali Judd
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
What constitutes adolescent-friendly health services? Clinic characteristics that attenuate internalised HIV stigma among adolescents living with HIV- Dr. Marija Pantelic
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Debate: Self-testing should be implemented for all adolescents - Pro- Cheryl Johnson
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Discussion: What constitutes “Adolescent Friendly” Programming?- Nicola Willis, MPhil
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Discussion: What constitutes “Adolescent Friendly” Programming?- Claude Mellins, PhD
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Debate: Self-testing should be implemented for all adolescents - Con- Gabriel Chamie, MD
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Discussion: What constitutes “Adolescent Friendly” Programming?- Catherine Dollfus, MD, MPH
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Current and Future Treatment of CMV- Robin Avery, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
O_1: Single- and multiple-ascending doses (SAD/MAD) and food effect of orally administered JNJ-64155806 in healthy volunteers- Thomas Kakuda, PharmD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
O_2: Effects of cobicistat on tenofovir durability: is it time to rethink at TAF trials?- Dario Cattaneo, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
O_4: Evaluation of the Drug-Drug Interaction Potential between Cobicistat-Boosted Protease Inhibitors and Statins - Dr Joseph Custodio
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
O_5: Confirmation of the drug-drug interaction (DDI) potential between cobicistat-boosted antiretroviral regimens and hormonal contraceptives- Dr Sophia Majeed
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
O_3: Pharmacokinetics of darunavir/cobicistat and etravirine alone and coadministered in HIV-infected patients- José Moltó, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
O_6: Darunavir concentrations in CSF of HIV-infected individuals when boosted with cobicistat versus ritonavir- Catia Marzolini, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
Current Challenges in Pediatric Drug Development- Robert Ward, MD, FAAP, FCP
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
Clinical Aspects of Pediatric Treatment- Tim Cressey, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017
Slidesets
O_8: Relationship between dolutegravir plasma exposure, quality of sleep and its functional outcome in patients living with HIV over the age of 60 years.- Marta Boffito, MD, PhD, FRCP
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017